The biosynthesis is initiated with the formation of GlcNAc-PP-Und (catalyzed by WecA), which is later epimerized to GalNAc-PP-Und by Gne 54 . Subsequently, the RU-PP-Und is assembled by three GTs (WbdN, WbdO and WbdP) and then translocated to the periplasmic face of the inner membrane by Wzx, where the repeating units are polymerized by Wzy to form O-PS in a block transfer mechanism that is regulated by Wzz. The last step includes WaaL-catalyzed transfer of O-PS onto an individually synthesized lipid A core structure to form the intact LPS. reports Woodward et al. 9 Holkenbrink et al. 33 lebar et al. 31 Huang et al. 32 Huang et al. 29 Gale et al. 30 Target compounds
RU-PP-Und and analogs
Trisaccharide-PP-Und invaluable in deciphering the molecular details of these pathways [22] [23] [24] [25] [26] [27] [28] . For example, by using chemoenzymatically prepared E. coli O86 RU-PP-Und and its analogs, it was shown that PglL, which is the oligosaccharyltransferase from the Neisseria meningitidis O-glycosylation pathway, is extremely promiscuous and can transfer a wide range of sugars onto proteins 27, 28 . Given that RU-PP-Und and other sugar-PP-Und compounds are direct substrates of key enzymes involved in bacterial PS, cell wall and teichoic acid biosynthesis, as well as protein glycosylation (e.g., Wzx, Wzy, WaaL and PglL), these compounds can be readily used to discover the finer details of these enzymes, including activity, kinetics, substrate specificity, biochemical properties and catalytic mechanisms, among others. Given this level of significance, similar methodologies have been developed to produce sugar-PP-Und in vitro, as summarized in Table 1 (refs. [29] [30] [31] [32] [33] . Nevertheless, to our knowledge, our report represents the only example of the in vitro synthesis of O-antigen RU-PP-Und to date 9 .
In this protocol, we use E. coli O157 as a model to describe the experimental details of the chemoenzymatic synthesis of bacterial RU-PP-Und and its analogs on a milligram scale. This protocol includes the following features: (i) step-by-step chemical synthesis of MS-PP-Und, starting with a commercially available monosaccharide and undecaprenol (or other polyprenols); (ii) biochemical identification of responsible GTs (Box 1), and the use of these GTs to perform sequential one-pot enzymatic extensions of GalNAc-PP-Und to synthesize RU-PP-Und (Box 2); and (iii) an application of the RU-PP-Und in an activity assay for WaaL. Given that most common sugar donors (sugar nucleotides) are commercially available, their synthesis will not be discussed here. The syntheses of uncommon sugar nucleotides found in various bacteria have been summarized elsewhere 34, 35 . As long as the structural information for a bacterial PS (see http://csdb. glycoscience.ru/bacterial/ for determined structures) and sugar nucleotides is available, and the corresponding GT genes (usually in a gene cluster such as rfb) have been sequenced, a similar protocol can be applied for the chemoenzymatic synthesis of the desired RU-PP-Und and other sugar-PP-Und compounds. The protocol can also be applied for the synthesis of RU-PP-Und derivatives, as long as the GTs can tolerate modified substrates. In these cases, initial small-scale tests are recommended to check whether the modified substrates are tolerated. Furthermore, GTs that are responsible for the addition of a second monosaccharide were found to be promiscuous toward the lipid moiety of MS-PP-Und [36] [37] [38] [39] [40] [41] [42] . Given that other GTs involved in the assembly of RU-PP-Und usually do not require the lipid moiety [43] [44] [45] [46] [47] , this procedure can thus be used for the preparation of a vast array of RU-PP-lipids analogs without compromising reaction yields (Step 1).
Development of the procedure E. coli O157, the most notorious strain of Shiga-toxin-producing E. coli, has been responsible for the majority of E. coli outbreaks during the past several decades 48 . Given the worldwide public health concerns associated with such outbreaks, E. coli O157 represents an especially relevant model strain for the analysis of the LPS biosynthetic pathway. The O-PS repeating unit of E. coli O157 consists of four sugar residues (PerNAc, l-Fuc, Glc and GalNAc), which are assembled into a structure, PerNAc-α1,3-l-Fuc-α1,4-Glc-β1,3-GalNAc-α1,2-(ref. 49 ; Fig. 1) ; this structure is shared by Salmonella enterica O30 and Citrobacter freundii F90 O-PSs 50 . The corresponding rfb gene cluster has been sequenced 51 , and orf1 (wbdN), orf2 (wbdO) and orf6 (wbdP; Fig. 2 ) were predicted Given that sequence analysis cannot usually predict GT function, it was essential to biochemically identify the remaining two GTs (see Box 1 as an example of GT identification). This approach can also be applied to any unknown GT involved in the synthesis of RU-PP-Und for the first time.
To perform this identification, a GalNAc-PP-Und building block had to first be chemically synthesized. Chemical synthesis of GalNAc-PP-Und (10) is initiated by the preparation of GalNAc-1-phosphate (5) (refs. 24,52,53) and Und-P (8) (Fig. 3) . Specifically, GalNAc (1) is first peracetylated using excess acetic anhydride and triethylamine to yield peracetylated GalNAc (2) . Selective anomeric deprotection of 2 with hydrazine acetate then produces anomerically deprotected peracetylated GalNAc (3). Treatment of 3 with dibenzyl N,N-diisopropylphosphoramidite in the presence of the acid/nucleophilic catalyst tetrazole yields the dibenzyl-protected phosphate of peracetylated GalNAc (4). Immediately before the coupling step needed to form GalNAc-PP-Und, this derivative undergoes hydrogenolysis to form peracetylated GalNAc-1-phosphate as the diisopropylethylammonium salt (5) . Similar phosphoramidite chemistry is applied to Und (6) to furnish protected Und-P (7) (ref. 52; Fig. 3) . However, the specific reagent must be altered to the bis(2-cyanoethyl)-N,N-diisopropylphosphoramidite equivalent so as to preserve the isoprene-based olefins in the deprotection step. The use of this phosphoramidite allows deprotection to then proceed via a base-mediated reaction to produce Und-P (8). Finally, coupling of peracetylated GalNAc-1-phosphate and Und-P makes use of a classical pyrophosphatebond-forming strategy 53 . Specifically, compound 5 is first activated for coupling through treatment with 1,1′-carbonyldiimidazole (CDI) (Fig. 3) . The addition of the activated species as a solution in tetrahydrofuran (THF) to compound 8 yields peracetylated GalNAc undecaprenyl pyrophosphate (9) after a period of 3 d. Base-catalyzed deprotection of this substrate then completes the chemical synthesis of GalNAc-PP-Und (10).
Upon successful synthesis of GalNAc-PP-Und, we were then able to identify the remaining two GTs and fully assemble the repeating unit donor.
Experimental design
The protocol described herein details (i) biochemical identification of GTs and (ii) how chemically prepared GalNAc-PP-Und can be synthesized and then used to generate E. coli O157 RU-PP-Und using the three GTs in a stepwise manner (Fig. 4) . A full overview of this experimental approach can be seen as a flowchart in Figure 5 .
Chemical synthesis of GalNAc-PP-Und (Steps 1-120) . The three-step synthesis of the dibenzyl-protected phosphate of peracetylated GalNAc from GalNAc can be readily performed on a gram scale, as described herein. However, should more material be needed for numerous coupling reactions, the scale of these steps can be adjusted without much adjustment in experimental protocol. However, we do not recommend adjusting the scale of the subsequent step in which peracetylated GalNAc-1-phosphate is formed via hydrogenolysis. This approach allowed us to avoid large-scale hydrogenations while still providing us with sufficient material for each coupling reaction, as the lipid phosphate was typically available in limited quantities. Larger-scale production of the lipid phosphate, as well as the coupled product, peracetylated GalNAc-PP-Und, will require further optimization of the corresponding reactions. Nevertheless, we have been able to apply this synthetic approach to various GalNAc-PP-lipid and GlcNAc-PP-lipid analogs that incorporate the following lipids: solanesol, heptaprenol, pentaprenol, cis-pentaprenol, monosaturated pentaprenol and farnesol. The use of these lipids and/or a different sugar residue did not noticeably alter reaction yields.
Enzymatic synthesis of E. coli O157 RU-PP-Und (Steps 121-158). As shown in Figure 5 , with identified GTS (Box 1), enzymatic synthesis of RU-PP-Und and analogs can be carried out either in a stepwise manner (Steps 121-158) or in a one-pot manner (Box 2). However, for first-time synthesis, it is recommended that one adopt the stepwise manner to gain familiarity with each enzyme-catalyzed reaction (e.g., how long each reaction takes and how much enzyme is needed). Milligrams of RU-PP-Und were synthesized in this protocol, an amount that is typically Box 2 | One-pot multistep synthesis of E. coli O157 RU-PP-Und • tIMInG 6 days Once RU-PP-Und has been successfully synthesized in a stepwise manner; an alternative one-pot approach may be applied for further synthesis. In this case, purification, lyophilization and resuspension steps for intermediates can be omitted to simplify the procedure. , 120 µl of GDP-PerNAc (100 mM) and 4.8 µl of rSAP (1,000 U/ml) to the tube. Mix well by shaking manually after the addition of each component. 11. Adjust the pH of the above mixture to 7.5-8.5.  crItIcal step Transfer 3 µl of the mixture onto a small piece of pH indicator strip. If the pH value is <7.5, add 1 M NaOH in 10-µl increments to adjust the pH. 12. Remove WbdP from a −20 °C freezer and allow it to thaw on ice. Remove 100 mM GDP-PerNAc mother solution from a −20 °C freezer and allow it to thaw at room temperature.  crItIcal step Refer to Step 121. 13. Transfer 100 µl of WbdP (5 mg/ml) to the tube and gently shake the tube to mix well. The total volume should be 4.8 ml. 14. Incubate the mixture and monitor the reaction as described in Steps 141 and 142. 15. Quench the reaction as described in Steps 129 and 130.  pause poInt After lyophilization, the mixture can be sealed with Parafilm and stored at −20 °C until purification can be performed (up to 2 weeks). 16 . Purify the RU-PP-Und by reverse-phase chromatography, as described in Steps 105-112. 17. Lyophilize the fractions to produce E. coli O157 RU-PP-Und as a white powder. 18. Confirm the identity of the isolated product using mass spectrometry.  pause poInt After lyophilization, the compound can be sealed in a container and stored at −20 °C indefinitely or until the next use. sufficient for biological applications. However, should more material be needed, the enzyme-catalyzed reaction can simply be scaled up (up to 200 mg of product) with appropriate adjustment of enzyme quantities and reaction times. In addition, using this protocol, various RU-PP-lipids can be readily prepared by simply replacing the starting material (GalNAc-PP-Und) with the desired GalNAc-PP-lipid. Certain steps may be changed or optimized for this purpose (e.g., DMSO and Triton X-100 can be omitted when lipids are highly soluble). We have been able to prepare various RU-PP-lipid analogs, including the following lipids: solanesol, heptaprenol, pentaprenol, cis-pentaprenol, monosaturated pentaprenol and farnesol. Separatory funnels (60-ml, 125-ml and 250-ml) Syringe (Sigma-Aldrich, cat. no. Z116874) REAGENT SETUP Sugar nucleotides The O-PS of E. coli O157 contains the common sugars Glc and l-Fuc (the corresponding sugar nucleotides UDP-Glc and GDP-l-Fuc are commercially available) and one rare sugar residue, PerNAc, the sugar nucleotide form of which is GDP-PerNAc. GDP-PerNAc is prepared as previously described (Supplementary Method 1) . UDP-Glc, GDP-l-Fuc and GDP-PerNAc should all be dissolved in dH 2 O to a final concentration of 100 mM and stored at −20 °C for up to 3 to 6 months. For the synthesis of RU-PP-Und from other bacteria, most of the common sugar nucleotides are commercially available, and synthesis of the uncommon sugar nucleotide has been reviewed elsewhere 34, 35 .  crItIcal GDP-l-Fuc is less stable than the other sugar nucleotides. Avoid storing it at −20 °C for longer than 3 months. Unused GDP-l-Fuc should be lyophilized for long-term storage. Enzymes The β1,3-glucosyltransferase WbdN and the other two putative GTs (WbdO and WbdP) should be cloned into expression vectors by using a standard cloning approach, and the vectors should be transformed into E. coli BL21(DE3) for overexpression and purification (please refer to Supplementary Method 2 for detailed experiments). Given that most GTs involved in the assembly of RU-PP-Und are membrane-bound proteins that tend to precipitate, it is recommended that 0.1-0.5% (vol/vol) of Triton X-100 or/and 5-20% (vol/vol) glycerol be used during purification to obtain soluble forms of these enzymes. However, high concentrations of Triton X-100 should be removed before performing reactions in the synthesis of RU-PP-Und. If the soluble form of certain GTs is still not accessible, it is recommended that a fusion protein strategy be applied. For example, WbdO can be fused to maltose-binding protein for soluble expression (Supplementary Method 2) . Before use of the enzymes for synthetic steps in the PROCEDURE, the activity of all putative GTs should be checked via small-scale reactions, as described in Box 1. E. coli O157 WaaL (the LPS ligase) is identical to E. coli O86 WaaL, which was previously successfully overexpressed and purified in our laboratory 18 . Shrimp alkaline phosphatase (rSAP) is commercially available at a concentration of 1,000 U/ml. All enzymes can be stored at −20 °C with 20% (vol/vol) glycerol and appropriate buffers for long-term use (up to 1 year). Lipid A core The lipid A core structure was previously prepared in our laboratory 18 , and it should be dissolved for a final concentration of 40 µM using dH 2 O. ! cautIon Given that lipid A is an endotoxin, one should avoid contact with any wounds.  crItIcal If visible particles are observed, sonicate for up to 20 min to promote dissolving of lipid A core.
MaterIals

REAGENTS
• Preparation of the p-anisaldehyde staining solution Add a stir bar and 200 ml of absolute ethanol to a 500-ml Erlenmeyer flask. Cool the ethanol to 0 °C and stir it at this temperature for 5 min. Carefully add 2.5 ml of glacial acetic acid and 5.5 ml of p-anisaldehyde to the flask. Using a 60-ml separatory funnel, slowly add 7.5 ml of concentrated sulfuric acid dropwise over a period of 5 min. Continue to stir the solution for 5 min, after which it can be transferred to an amber storage vial and be stored at 4 °C for up to 3 months. ! cautIon Preparation of the staining solution requires the handling of concentrated acids. Personal protective equipment including goggles and gloves should be worn when it is used. Mass spectrometry In this protocol, all electrospray ionization mass spectral data were collected using a Shimadzu LCMS-2010, a liquid chromatograph mass spectrometer under negative mode with direct infusion. Other mass spectrometers could also be used. 
5|
Warm the mixture to room temperature (25 °C) and stir it for an additional 1 h.
6|
Cool the mixture to 0 °C and add 10 µl of pyridine and 17 mg of NaIO 4 sequentially.  crItIcal step It is imperative to cool the flask before the addition of these reagents to avoid a sudden increase in temperature and a concomitant decrease in overall yield.
7|
Stir the mixture for 15 min at 0 °C.
8|
Warm the mixture to room temperature and stir it for an additional 1 h.
9|
Dilute the mixture with 10 ml of ethyl acetate and transfer the it to a 60-ml separatory funnel.
10|
Wash the organic fraction successively with 10 ml each of deionized H 2 O, 5% (wt/vol) Na 2 SO 3 and saturated NaCl (aq.).
11|
Transfer the organic fraction to a 25-ml Erlenmeyer flask, and dry the organic layer over Na 2 SO 4 (a quantity sufficient to yield freely moving salt granules) for 10 min.
12|
Filter the organic fraction through a funnel containing a cotton plug into a 25-ml round-bottom flask.
13|
Remove the solvent in vacuo using a water bath set at a temperature of 25 °C.
14| Dissolve the residue in 10 ml of 1% (wt/vol) NaOCH 3 in CH 3 OH solution.
15|
Stir the mixture at room temperature for 3 d. 16| Remove the solvent in vacuo using a water bath set at a temperature of 25 °C.  pause poInt The 25-ml round-bottom flask can be sealed with a septum and stored at −20 °C until the purification can be performed (up to 1 week).
purification of und-p • tIMInG ~2 h 17| Dissolve the residue from Step 16 in 1 ml of CH 3 OH.
18|
Open the stopcock of a DEAE cellulose ion-exchange column (0.75-inch i.d. × 12-inch EL) to allow the solvent used during packing to reach the top of the ion-exchange bed.
19| Slowly add the solution from
Step 17 to the top of the column, allowing the solution to flow into the column until it reaches the top of the ion-exchange bed.
20|
Rinse the round-bottom flask with an additional 0.5 ml of CH 3 OH, and slowly add this solution to the top of the column, allowing the solution to flow into the column until it reaches the top of the ion-exchange bed.
21| Add 100 ml of 1:3 CH 3 OH:CHCl 3 (vol/vol) to the column to begin the elution. Collect the eluent in 20 10-ml test tubes.
22|
Add 100 ml of a 30-mM NH 4 HCO 3 in CH 3 OH solution and continue the elution. Collect the eluent in 20 10-ml test tubes.
23| Dilute 5 µl of each fraction in 0.5 ml of CH 3 OH, and analyze each sample using mass spectrometry under negative mode to discern the location of the desired product (m/z = 846).
24|
Combine the product-containing fractions into a 50-ml round-bottom flask.
25|
Remove the solvent in vacuo using a water bath set at a temperature of 25 °C to produce Und-P as a white powder. A representative yield is 26 mg (79%).
? troublesHootInG  pause poInt The 25-ml round-bottom flask can be sealed with a septum and stored at 4 °C indefinitely or until the subsequent coupling step can be performed. 27| Seal the flask with a septum and briefly place it under vacuum to evacuate the flask.
28| Fill the flask with N 2 using an N 2 -filled balloon, and then repeat this evacuation/filling process two additional times.
29| Add 25 ml of anhydrous CH 3 CN and 6.65 ml of triethylamine, and then cool the mixture to 0 °C. 30| Add 6.65 ml of acetic anhydride dropwise, and stir the mixture at 0 °C until the solution becomes clear (~2 h).
31|
Warm the solution to room temperature and stir it for an additional 2 h.
32|
Cool the solution to 0 °C and add 9.1 ml of CH 3 OH.
33|
Stir the solution for 30 min at 0 °C.
34|
Remove the solvent in vacuo using a water bath set at a temperature of 25 °C, and then dissolve the residue in 50 ml of CH 2 Cl 2 .
35|
Transfer the contents of the flask to a 250-ml separatory funnel. 36| Wash the organic fraction successively with 25 ml of 1 M HCl (aq.), 2 × 25 ml of 5% (wt/vol) NaHCO 3 (aq.) and 25 ml of saturated NaCl (aq.).
37|
Transfer the organic fraction to a 250-ml Erlenmeyer flask and dry the organic layer over Na 2 SO 4 (a quantity sufficient to yield freely moving salt granules) for 10 min.
38|
Filter the organic fraction through a funnel containing a cotton plug into a 100-ml round-bottom flask.
39|
Remove the solvent in vacuo using a water bath set at a temperature of 25 °C.  pause poInt The 250-ml round-bottom flask can be sealed with a septum and stored at 4 °C indefinitely or until the subsequent reaction can be performed.
purification of peracetylated Galnac
• tIMInG ~2 h 40| Dissolve the residue from Step 39 in 5 ml of 2:1 hexane:acetone (vol/vol).
41|
Open the stopcock of a silica gel column (1 1/2-inch i.d. × 18-inch EL) to allow the solvent used during packing (2:1 hexane:acetone (vol/vol)) to reach the top of the silica gel bed.
42| Slowly add the solution from
Step 40 to the top of the column, allowing the solution to flow into the column until it reaches the top of the silica gel bed.
43|
Rinse the round-bottom flask with an additional 2 ml of 2:1 hexane:acetone (vol/vol) and slowly add this solution to the top of the column, allowing the solution to flow into the column until it reaches the top of the silica gel bed.
44| Add 100 ml of 2:1 hexane:acetone (vol/vol) to the column to begin the elution. Collect the eluent in 15 10-ml test tubes.
45| Add 100 ml of 1:1 hexane:acetone (vol/vol) and continue the elution. Collect the eluent in 15 10-ml test tubes.
46|
Analyze the fractions using thin-layer chromatography (TLC; 25-mm × 75-mm plate) with a 1:1 hexane:acetone (vol/vol) mobile phase. Stain the TLC plates with a p-anisaldehyde solution and apply heat via a heat gun to discern the location of the desired product (brown spot at f = 0.25). ! cautIon The staining solution contains concentrated acids and is thus corrosive. Personal protective equipment including goggles and gloves should be worn when it is used.
47|
Combine the product-containing fractions in a 100-ml round-bottom flask.
48|
Remove the solvent in vacuo using a water bath set at a temperature of 25 °C to produce peracetylated GalNAc as a white foam. A representative yield is 1.450 g (92%).  pause poInt The 100-ml round-bottom flask can be sealed with a septum and stored at 4 °C indefinitely or until the subsequent reaction can be performed.
preparation of anomerically deprotected peracetylated Galnac
• tIMInG ~1 h 49| Add 1.450 g of peracetylated GalNAc and a stir bar to a 100-ml round-bottom flask.
50| Add 20 ml of anhydrous N,N-dimethylformamide and 0.412 g of hydrazine acetate.
51|
Stir the mixture for 40 min at room temperature.
52|
Remove the solvent in vacuo using a water bath set at a temperature of 25 °C.  pause poInt The 100-ml round-bottom flask can be sealed with a septum and stored at 4 °C indefinitely or until the subsequent reaction can be performed. 54| Open the stopcock of a silica gel column (1 1/2-inch i.d. × 18-inch EL) to allow the solvent used during packing (1:1 hexane:acetone (vol/vol)) to reach the top of the silica gel bed.
55| Slowly add the solution from
Step 53 to the top of the column, allowing the solution to flow into the column until it reaches the top of the silica gel bed.
56|
Rinse the round-bottom flask with an additional 2 ml of 1:1 hexane:acetone (vol/vol) and slowly add this solution to the top of the column, allowing the solution to flow into the column until it reaches the top of the silica gel bed.
57| Add 100 ml of 1:1 hexane:acetone (vol/vol) to the column to begin the elution. Collect the eluent in 15 10-ml test tubes.
58| Add 100 ml of 1:2 hexane:acetone (vol/vol) and continue the elution. Collect the eluent in 15 10-ml test tubes.
59|
Analyze the fractions using TLC (25-mm × 75-mm plate) with a 1:1 hexane:acetone (vol/vol) mobile phase. Stain the TLC plates with a p-anisaldehyde solution, and apply heat via a heat gun to discern the location of the desired product (brown spot at f = 0.2). ! cautIon The staining solution contains concentrated acids and is thus corrosive. Personal protective equipment including goggles and gloves should be worn when it is used.
60|
61|
Remove the solvent in vacuo using a water bath set at a temperature of 25 °C to produce anomerically deprotected peracetylated GalNAc as a white foam. A representative yield is 1.031 g (80%).  pause poInt The 100-ml round-bottom flask can be sealed with a septum and stored at 4 °C indefinitely or until the subsequent reaction can be performed.
preparation of the dibenzyl-protected phosphate of peracetylated Galnac
• tIMInG ~18 h 62| Add 1.031 g of anomerically deprotected peracetylated GalNAc, 2.080 g of tetrazole and a stir bar to a 100-ml round-bottom flask.
63|
Seal the flask with a septum and briefly place it under vacuum to evacuate it.
64|
Fill the flask with N 2 using an N 2 -filled balloon and then repeat this evacuation/filling process two additional times.
65| Add 35 ml of CH 2 Cl 2 and cool the mixture to −40 °C.
66| Add 4.99 ml of dibenzyl N,N-diisopropylphosphoramidite dropwise over a period of 5 min.
67| Stir the mixture for 3 h as it warms to room temperature.
68|
Cool the mixture to −78 °C and add 5.125 g of mCPBA in two portions.
69|
Allow the mixture to warm to room temperature overnight.
70|
Transfer the contents of the flask to a 125-ml separatory funnel.
71|
Wash the organic fraction successively with 15 ml each of saturated Na 2 SO 3 (aq.), deionized H 2 O and saturated NaCl (aq.).
72|
Transfer the organic fraction to a 125-ml Erlenmeyer flask and dry the organic layer over Na 2 SO 4 (a quantity sufficient to yield freely moving salt granules) for 10 min.
73|
74|
Remove the solvent in vacuo using a water bath set at a temperature of 25 °C.  pause poInt The 100-ml round-bottom flask can be sealed with a septum and stored at 4 °C overnight. 76| Open the stopcock of a silica gel column (1 1/2-inch i.d. × 18-inch EL) to allow the solvent used during packing (CH 2 Cl 2 ) to reach the top of the silica gel bed.
77| Slowly add the solution from
Step 75 to the top of the column, allowing the solution to flow into the column until it reaches the top of the silica gel bed.
78|
Rinse the round-bottom flask with an additional 2 ml of CH 2 Cl 2 , and slowly add this solution to the top of the column, allowing the solution to flow into the column until it reaches the top of the silica gel bed.
79| Add 100 ml of CH 2 Cl 2 to the column to begin the elution. Collect the eluent in 15 10-ml test tubes.
80| Add 100 ml of a 1% (vol/vol) CH 3 OH in CH 2 Cl 2 solution and continue the elution. Collect the eluent in 15 10-ml test tubes.
81| Add 100 ml of a 2% (vol/vol) CH 3 OH in CH 2 Cl 2 solution, and continue the elution. Collect the eluent in 15 10-ml test tubes.
82|
Analyze the fractions using TLC (25-mm × 75-mm plate) with a 2% (vol/vol) CH 3 OH in CH 2 Cl 2 mobile phase. Stain the TLC plates with a p-anisaldehyde solution and apply heat via a heat gun to discern the location of the desired product (brown spot at f = 0.2). ! cautIon The staining solution contains concentrated acids and is thus corrosive. Personal protective equipment including goggles and gloves should be worn when it is used.
83|
84|
Remove the solvent in vacuo using a water bath set at a temperature of 25 °C to produce the dibenzyl-protected phosphate of peracetylated GalNAc as a white foam. A representative yield is 1.262 g (70%).  pause poInt The 100-ml round-bottom flask can be sealed with a septum and stored at 4 °C indefinitely or until the hydrogenolysis reaction can be performed. The scale of these first three reactions provides sufficient material to perform several iterations of the subsequent reactions, which may make use of Und-P (8) or other lipid phosphates.
preparation of peracetylated Galnac-1-phosphate • tIMInG ~2 h 85| Add 15 mg of 20% (wt/vol) Pd(OH) 2 on carbon and a stir bar to a 25-ml round-bottom flask.
86|
87|
Fill the flask with N 2 and then repeat this evacuation/filling process two additional times.
88|
After moistening the catalyst with a minimal amount of ethyl acetate, slowly add 4.5 ml of CH 3 OH to the sealed flask.
89| Dissolve 90 mg of the dibenzyl-protected phosphate of peracetylated GalNAc in 0.5 ml of CH 3 OH, and add this solution to the flask.
90|
Evacuate the flask and then fill it with H 2 using an H 2 -filled balloon. ! cautIon Hydrogen gas is highly flammable.
91| Repeat
Step 90 two additional times.
91|
Stir the mixture for 30 min at room temperature.
93|
Carefully remove the balloon and bubble N 2 through the solution. ! cautIon Hydrogen gas is highly flammable. 
94|
95|
Filter the solution through a syringe containing a pad of Celite into a 25-ml round-bottom flask. ! cautIon Be sure to avoid filtering to dryness, as this represents a flammability hazard. After filtration is completed, several milliliters of H 2 O should be added to the filter before disposing of it in a specified waste container.
96|
Remove the solvent in vacuo using a water bath set at a temperature of 25 °C to produce the crude peracetylated GalNAc-1-phosphate, which will be used directly in the coupling reaction.  pause poInt The 25-ml round-bottom flask can be sealed with a septum and stored at 4 °C indefinitely or until the coupling step can be performed.
preparation of Galnac-pp-und • tIMInG 7 d  crItIcal These steps can also be used to prepare solanesol-, heptaprenol-, pentaprenol-, cis-pentaprenol-, monosaturated pentaprenol-and farnesol-based products. 97| Add 23 mg of CDI and 23 mg of peracetylated GalNAc-1-phosphate to a 25-ml round-bottom flask, sealing it with a septum.
98|
Briefly place the flask under vacuum to evacuate it. Fill the flask with argon using an argon-filled balloon, and then repeat this evacuation/filling process two additional times.
99| Add 3 ml of anhydrous THF and stir the mixture at room temperature for 2 h.  crItIcal step Formation of CDI-activated peracetylated GalNAc-1-phosphate can be confirmed by removing 5 µl of the reaction solution, diluting it with 0.5 ml CH 3 OH and analyzing the sample using mass spectrometry under negative mode (m/z = 476).
100| Add 42 µl of anhydrous CH 3 OH and stir the mixture at room temperature for 1 h.  crItIcal step This step will remove the excess CDI to prevent a reaction between CDI and Und-P upon introduction of the latter.
101|
Remove the solvent in vacuo using a water bath set at a temperature of 25 °C to produce CDI-activated peracetylated GalNAc-1-phosphate.  crItIcal step CDI-activated peracetylated GalNAc-1-phosphate should be used immediately in the next step.
102| Add 3 ml of anhydrous THF to the residue and transfer this solution to a separate 25-ml round-bottom flask (sealed with a septum and flushed with argon) containing 23 mg of Und-P. ? troublesHootInG 103| Stir the mixture at room temperature for 3 d.
104|
105| Add 1 ml of H 2 O to the residue from
Step 104. The solution will be cloudy in appearance.
106|
Open the stopcock of a C-18 reverse-phase column (0.5-inch i.d. × 8-inch EL) to allow the water used during packing to reach the top of the silica gel bed.
107| Slowly add the solution from
Step 105 to the top of the column, allowing the solution to flow into the column until it reaches the top of the silica gel bed.
108|
Rinse the round-bottom flask with an additional 0.5 ml of H 2 O and slowly add this solution to the top of the column, allowing the solution to flow into the column until it reaches the top of the silica gel bed.
109| Add 10 ml of 1.7% (wt/vol) NH 4 HCO 3 (aq.) to the column to begin the elution. Collect the eluent in two 10-ml test tubes.
110| Add 10 ml of a 5% solution of isopropanol (vol/vol) in 1.7% (wt/vol) NH 4 HCO 3 (aq.) and continue the elution. The amount of isopropanol should be increased by 5% for each 10 ml of eluent used until a 50% solution is used. Collect the eluent in two 10-ml test tubes for each 10 ml of eluent used.  crItIcal step Isopropanol is a suitable organic solvent for the purification of undecaprenol-and solanesol-based products, whereas acetonitrile is a suitable organic solvent for heptaprenol-, pentaprenol-, cis-pentaprenol-, monosaturated pentaprenol-and farnesol-based products. 3 OH and analyze each sample using mass spectrometry under negative mode to discern the location of the desired product (m/z = 1,254).
112|
Combine the product-containing fractions in a 50-ml round-bottom flask.
113|
Lyophilize the fractions to produce peracetylated GalNAc-PP-Und as a white powder. A representative isolated yield is 20 mg (59%).
114|
Because of the amphiphilic nature of GalNAc-PP-Und, 1 H, 13 C and 31 P-NMR characterization should be performed on the peracetylated precursor isolated in Step 113. Mass spectrometry analysis can be performed on both molecules (GalNAc-PP-Und and the peracetylated precursor).
115| Add 3 ml of a 0.1% (wt/vol) NaOCH 3 in CH 3 OH solution to a 10-ml round-bottom flask containing the white powder obtained in
Step 113.
116|
Seal the flask with a septum, and stir the mixture at room temperature for 40 min.
117|
118|
Repeat Steps 105-112 to ensure purity of the material obtained in
Step 117.
119|
Lyophilize the fractions to produce GalNAc-PP-Und as a white powder. A representative isolated yield is 18 mg (99%).
120|
Confirm the identity of the isolated product using mass spectrometry.  pause poInt The lyophilized GalNAc-PP-Und can be sealed and stored at −20 °C indefinitely or until the enzymatic reactions can be performed.
preparation of disaccharide-pp-und • tIMInG 3 d
 crItIcal Before performing large-scale syntheses, it is highly recommended that small-scale reactions (e.g., 20 µl total volume reaction) be performed to confirm the activity of each enzyme. For the synthesis of RU-PP-lipids, simply replace GalNAc-PP-Und with the same number of moles of different GalNAc-PP-lipids. 121| Remove WbdN from a −20 °C freezer and allow it to thaw on ice. Remove the 100 mM UDP-Gal from a −20 °C freezer and allow it to thaw at room temperature.  crItIcal step WbdN should be stored in 0.1-ml aliquots at −20 °C (for up to 1 year) to avoid repeated freezing and thawing.
122| Add 11.7 mg (10 µmol) of chemically synthesized GalNAc-PP-Und to a 15-ml centrifuge tube.
123|
Transfer 200 µl of DMSO and 400 µl of 10% (vol/vol) Triton X-100 to the tube. Vortex the tube for 1 min, and then place the tube into the water bath (room temperature) of the Bransonic Tabletop Cleaner. Sonicate the mixture to completely dissolve the GalNAc-PP-Und. The sonication may take up to 30 min.  crItIcal step Be sure to make 10% (vol/vol) Triton X-100 first and add this solution. Do not add pure Triton X-100 and dH 2 O. Monitor the dissolution of GalNAc-PP-Und to ensure that there are no visible particles. For GalNAc-PP-lipids with high water solubility, for example, GalNAc-PP-farnesyl, use H 2 O to dissolve the GalNAc-PP-Und and skip this step. 
125|
Transfer 100 µl of WbdN (5 mg/ml) to the tube and gently shake the tube to mix well.
126|
The total volume of the reaction mixture is 4 ml, and it contains 20 mM Tris-HCl (pH 8.0), 2.5 mM GalNAc-PP-Und, 3 mM UDP-Glc (1.2 equiv.), 10 mM MnCl 2 , 1% (vol/vol) Triton X-100, 5% (vol/vol) DMSO, 1 U/ml rSAP and 0.125 mg/ml WbdN.
127|
Incubate the reaction mixture at 37 °C in a water bath for 6 h with occasional gentle shaking. 
128|
Monitor the reaction by mass spectrometry. Remove 1 µl of the reaction mixture and mix it with 9 µl of 1:1 H 2 O:CH 3 OH (vol/vol) in a 1.5-ml Eppendorf tube. Centrifuge the mixture at 15,000g at room temperature for 5 min with an Eppendorf centrifuge and inject 5 µl of the supernatant into an electrospray ionization mass spectrometer for analysis under negative mode. The starting material (GalNAc-PP-Und) is typically consumed within 6 h, depending upon the activity of the corresponding GT. If not, monitor the reaction every 6 h until the starting material is totally consumed.  crItIcal step Check the mass spectrum for m/z values corresponding to the substrate and the product with both single and double charges (Fig. 6) .
? troublesHootInG 129| When the starting material disappears or its corresponding m/z values become minute compared with those of the product, quench the reaction by boiling the mixture for 5 min in a water bath.
130|
Transfer the reaction mixture to four 1.7-ml Eppendorf tubes, and centrifuge them at 15,000g at room temperature for 10 min.
131|
Transfer the supernatant to a 15-ml centrifuge tube and lyophilize the mixture using a freeze dryer.  pause poInt After lyophilization, the tube can be sealed with Parafilm and stored at −20 °C until purification is performed (up to 2 weeks).
132|
Purify the disaccharide-PP-Und by reverse-phase chromatography, as described in Steps 105-112.
133|
Lyophilize the fractions to produce E. coli O157 disaccharide-PP-Und as a white powder.
134|
Confirm the identity of the isolated product using mass spectrometry.  pause poInt After lyophilization, the compound can be sealed and stored at −20 °C indefinitely or until the next step can be performed.
preparation of trisaccharide-pp-und • tIMInG 3 d  crItIcal WbdO is responsible for the addition of l-Fuc to trisaccharide-PP-Und (box 1). 135|remove WbdO from a −20 °C freezer and allow it to thaw on ice. Remove 100 mM GDP-l-Fuc mother solution from a −20 °C freezer and allow it to thaw at room temperature.  crItIcal step Refer to Step 121. 136|add 10.6 mg (8 µmol) of disaccharide-PP-Und from
Step 133 to a 15-ml centrifuge tube.  crItIcal step It is recommended that a small portion of the disaccharide-PP-Und be kept for later or further use. In our case, 1.5 µmol was kept, and 8 µmol was used as the substrate for trisaccharide-PP-Und synthesis. 139| Transfer 160 µl of WbdO (5 mg/ml) to the tube and gently shake the tube to mix well.
140|
The total volume of the reaction mixture is 3.2 ml, and it contains 20 mM Tris-HCl (pH 8.0), 2.5 mM disaccharide-PP-Und, 3 mM GDP-l-Fuc (1.2 equiv.), 10 mM MnCl 2 , 1% (vol/vol) Triton X-100, 5% (vol/vol) DMSO, 1 U/ml rSAP and 0.25 mg/ml WbdO.  crItIcal step Refer to Step 126.
141|
144|
Purify the trisaccharide-PP-Und by reverse-phase chromatography, as described in Steps 105-112.
145|
Lyophilize the fractions to produce E. coli O157 trisaccharide-PP-Und as a white powder.
146|
preparation of E. coli o157 ru-pp-und • tIMInG 3 d 147| Remove WbdP from a −20 °C freezer and allow it to thaw on ice. Remove 100 mM GDP-PerNAc mother solution from a −20 °C freezer and allow it to thaw at room temperature.  crItIcal step Refer to Step 121.
148| Add 8.85 mg (6 µmol) of trisaccharide-PP-Und from
Step 145 to a 15-ml centrifuge tube.  crItIcal step It is recommended that a small portion of the trisaccharide-PP-Und be kept for later or further use. In our case, 1.2 µmol was kept, and 6 µmol was used as the substrate for RU-PP-Und synthesis.
149|
Transfer 120 µl of DMSO and 240 µl of 10% (vol/vol) Triton X-100 to the tube. Vortex the tube for 1 min and place it into the water bath (room temperature) of the Bransonic Tabletop Cleaner. Sonicate to completely dissolve the trisaccharide-PP-Und.  crItIcal step Refer to Step 137. 
152|
The total volume of the reaction mixture is 2.4 ml, and it contains 20 mM Tris-HCl (pH 8.0), 2.5 mM trisaccharide-PP-Und, 3 mM GDP-PerNAc (1.2 equiv.), 10 mM MnCl 2 , 1% (vol/vol) Triton X-100, 5% (vol/vol) DMSO, 1 U/ml rSAP and 0.125 mg/ml WbdP.  crItIcal step Refer to Step 126.
153|
Incubate the reaction mixture at 37 °C in a water bath for 6 h, with occasional gentle shaking.
154|
Monitor the reaction by mass spectrometry. Remove 1 µl of the reaction mixture and mix it with 9 µl of 1:1 H 2 O:CH 3 OH (vol/vol) in an Eppendorf tube. Centrifuge the mixture at 15,000g at room temperature for 5 min with an Eppendorf centrifuge, and inject 5 µl of the supernatant into an ESI-MS for analysis under negative mode. Starting material usually will be consumed within 6 h, depending on the activity of the corresponding GT.  crItIcal step Refer to Step 128. ? troublesHootInG 155| Quench the reaction and lyophilize the product, as described in Steps 129-131.  pause poInt After lyophilization, the tube can be sealed with Parafilm and stored at −20 °C for up to 2 weeks or until purification can be performed.
156|
Purify the RU-PP-Und by reverse-phase chromatography, as described in Steps 105-112.
157|
Lyophilize the fractions to produce E. coli O157 RU-PP-Und as a white powder.
158| Confirm the identity of the isolated product using mass spectrometry. 
168|
Analyze the reactions and controls (reactions at 0 min) using western blotting (E. coli O157 anti-serum as first antibody) and SDS-PAGE/silver staining (Fig. 7) , as described previously 18 .
? troublesHootInG Troubleshooting advice can be found in table 2.
• 
antIcIpateD results
The PROCEDURE describes the chemical synthesis of GalNAc-PP-Und beginning with GalNAc and Und. Preparation of the dibenzyl-protected phosphate of peracetylated GalNAc in our case entailed a sequence of three chemical steps with an overall yield of 52%, whereas Und-P was prepared directly from Und with a yield of 79%. Benzyl group removal and subsequent activation of peracetylated GalNAc-1-phosphate enabled pyrophosphate bond formation. This step initially yielded minimal product because of the physical state of the Und-P upon purification (waxy residue). However, after the addition of a small amount of hexane, rotary evaporation, and adequate drying under vacuum, a white powder was produced that allowed yields to be consistently obtained at the 59% level. Subsequent deprotection produced the desired GalNAc-PP-Und product in a 99% yield (18 mg). Although these yields represent optimal results, variation among trials This residue will take on a white powder form after the addition of 1-2 ml of hexanes, rotary evaporation, and drying under vacuum. This form greatly facilitates transfer of the product to another container should this process be necessary
Step 128 Starting material not completely consumed Add another 100 µl of WbdN and incubate for 12 h at 37 °C
Step 142 Starting material not completely consumed Add another 160 µl of WbdO and 40 µl of GDP-l-Fuc, and incubate for 12 h at 37 °C
Step did not exceed 10%. It should furthermore be noted that this synthesis can be extended to lipids other than Und, including but not limited to solanesol, heptaprenol, pentaprenol, cis-pentaprenol, monosaturated pentaprenol and farnesol. Enzymatic synthesis of RU-PP-Und from the chemically prepared GalNAc-PP-Und was then accomplished with a total yield of >70% (expecting >90% yield in each GT catalyzed step) on semipreparative scales (9 mg; Fig. 6 ). RU-PP-lipids can also be synthesized with >70% yield on semipreparative scales (see supplementary Data 1 for mass spectra of RU-PP-farnesyl and RU-PP-monosaturated-pentaprenyl). During the enzymatic synthesis of RU-PP-Und, the specific activity of putative GTs involved in the assembly of the repeating units can be identified. For example, in this case, WbdO and WbdP are identified as the α1,4-fucosyltransferase and α1,3-N-acetylperosaminyltransferase, respectively.
The protocol for the activity assay of WaaL using synthesized RU-PP-Und furthermore provides visible results regarding the activity of WaaL. As shown in Figure 7 , RU-PP-Und is visible in the western blot (Fig. 7b, lane 5 ) using E. coli O157 anti-serum as the first antibody. This evidence confirms the structure of synthesized RU-PP-Und, given that the anti-serum is specific for E. coli O157 structures. Although RU-PP-Und cannot be visualized in SDS-PAGE/silver staining (Fig. 7a,  lane 5) , lipid A core can be visualized by both western blot analysis and silver staining (Fig. 7a,b, lane 6 ). After incubating with WaaL for 12 h, the band corresponding to RU-PP-Und, which was initially present (Fig. 7b, lane 3) , disappeared and a new band above lipid A core was observed (Fig. 7b, lane 4) , which correspond to the RU-lipid A core product. SDS-PAGE confirmed the formation of the product (Fig. 7a, lane 4) .
analytical data
